| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Aluminum-containing vaccine associated adverse events: role of route of administration and gender
|
Pittman, Phillip R.
|
|
2002
|
20 |
S3 |
p. S48-S50
3 p.
|
article
|
| 2 |
Aluminum salts in vaccines—US perspective
|
Baylor, Norman W.
|
|
2002
|
20 |
S3 |
p. S18-S23
6 p.
|
article
|
| 3 |
Aluminum toxicokinetics regarding infant diet and vaccinations
|
Keith, L.S.
|
|
2002
|
20 |
S3 |
p. S13-S17
5 p.
|
article
|
| 4 |
Considerations and procedures in the derivation of ATSDR minimal risk levels
|
Wheeler, John S
|
|
2002
|
20 |
S3 |
p. S51-S55
5 p.
|
article
|
| 5 |
Design and selection of vaccine adjuvants: animal models and human trials
|
Alving, Carl R.
|
|
2002
|
20 |
S3 |
p. S56-S64
9 p.
|
article
|
| 6 |
Elimination of aluminum adjuvants
|
Hem, Stanley L.
|
|
2002
|
20 |
S3 |
p. S40-S43
4 p.
|
article
|
| 7 |
Lack of consistent relationship between quantity of aluminum in diphtheria–tetanus–acellular pertussis vaccines and rates of extensive swelling reactions
|
Rennels, Margaret B.
|
|
2002
|
20 |
S3 |
p. S44-S47
4 p.
|
article
|
| 8 |
Macrophagic Myofasciitis: a summary of Dr. Gherardi’s presentations
|
Brenner, A.
|
|
2002
|
20 |
S3 |
p. S5-S6
2 p.
|
article
|
| 9 |
Mechanisms of stimulation of the immune response by aluminum adjuvants
|
HogenEsch, Harm
|
|
2002
|
20 |
S3 |
p. S34-S39
6 p.
|
article
|
| 10 |
Overview of vaccine adjuvants: present and future
|
Hunter, Robert L.
|
|
2002
|
20 |
S3 |
p. S7-S12
6 p.
|
article
|
| 11 |
The global impact of vaccines containing aluminium adjuvants
|
Clements, C.J.
|
|
2002
|
20 |
S3 |
p. S24-S33
10 p.
|
article
|
| 12 |
Workshop summary
|
Eickhoff, Theodore C.
|
|
2002
|
20 |
S3 |
p. S1-S4
4 p.
|
article
|
Journal description